Biosynthesis of natural and halogenated plant monoterpene indole alkaloids in yeast
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Biosynthesis of natural and halogenated plant monoterpene indole alkaloids in yeast. / Bradley, Samuel A.; Lehka, Beata J.; Hansson, Frederik G.; Adhikari, Khem B.; Rago, Daniela; Rubaszka, Paulina; Haidar, Ahmad K.; Chen, Ling; Hansen, Lea G.; Gudich, Olga; Giannakou, Konstantina; Lengger, Bettina; Gill, Ryan T.; Nakamura, Yoko; de Bernonville, Thomas Dugé; Koudounas, Konstantinos; Romero-Suarez, David; Ding, Ling; Qiao, Yijun; Frimurer, Thomas M.; Petersen, Anja A.; Besseau, Sébastien; Kumar, Sandeep; Gautron, Nicolas; Melin, Celine; Marc, Jillian; Jeanneau, Remi; O’Connor, Sarah E.; Courdavault, Vincent; Keasling, Jay D.; Zhang, Jie; Jensen, Michael K.
In: Nature Chemical Biology, Vol. 19, No. 12, 2023, p. 1551-1560.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Biosynthesis of natural and halogenated plant monoterpene indole alkaloids in yeast
AU - Bradley, Samuel A.
AU - Lehka, Beata J.
AU - Hansson, Frederik G.
AU - Adhikari, Khem B.
AU - Rago, Daniela
AU - Rubaszka, Paulina
AU - Haidar, Ahmad K.
AU - Chen, Ling
AU - Hansen, Lea G.
AU - Gudich, Olga
AU - Giannakou, Konstantina
AU - Lengger, Bettina
AU - Gill, Ryan T.
AU - Nakamura, Yoko
AU - de Bernonville, Thomas Dugé
AU - Koudounas, Konstantinos
AU - Romero-Suarez, David
AU - Ding, Ling
AU - Qiao, Yijun
AU - Frimurer, Thomas M.
AU - Petersen, Anja A.
AU - Besseau, Sébastien
AU - Kumar, Sandeep
AU - Gautron, Nicolas
AU - Melin, Celine
AU - Marc, Jillian
AU - Jeanneau, Remi
AU - O’Connor, Sarah E.
AU - Courdavault, Vincent
AU - Keasling, Jay D.
AU - Zhang, Jie
AU - Jensen, Michael K.
N1 - Publisher Copyright: © 2023, The Author(s).
PY - 2023
Y1 - 2023
N2 - Monoterpenoid indole alkaloids (MIAs) represent a large class of plant natural products with marketed pharmaceutical activities against a wide range of indications, including cancer, malaria and hypertension. Halogenated MIAs have shown improved pharmaceutical properties; however, synthesis of new-to-nature halogenated MIAs remains a challenge. Here we demonstrate a platform for de novo biosynthesis of two MIAs, serpentine and alstonine, in baker’s yeast Saccharomyces cerevisiae and deploy it to systematically explore the biocatalytic potential of refactored MIA pathways for the production of halogenated MIAs. From this, we demonstrate conversion of individual haloindole derivatives to a total of 19 different new-to-nature haloserpentine and haloalstonine analogs. Furthermore, by process optimization and heterologous expression of a modified halogenase in the microbial MIA platform, we document de novo halogenation and biosynthesis of chloroalstonine. Together, this study highlights a microbial platform for enzymatic exploration and production of complex natural and new-to-nature MIAs with therapeutic potential.
AB - Monoterpenoid indole alkaloids (MIAs) represent a large class of plant natural products with marketed pharmaceutical activities against a wide range of indications, including cancer, malaria and hypertension. Halogenated MIAs have shown improved pharmaceutical properties; however, synthesis of new-to-nature halogenated MIAs remains a challenge. Here we demonstrate a platform for de novo biosynthesis of two MIAs, serpentine and alstonine, in baker’s yeast Saccharomyces cerevisiae and deploy it to systematically explore the biocatalytic potential of refactored MIA pathways for the production of halogenated MIAs. From this, we demonstrate conversion of individual haloindole derivatives to a total of 19 different new-to-nature haloserpentine and haloalstonine analogs. Furthermore, by process optimization and heterologous expression of a modified halogenase in the microbial MIA platform, we document de novo halogenation and biosynthesis of chloroalstonine. Together, this study highlights a microbial platform for enzymatic exploration and production of complex natural and new-to-nature MIAs with therapeutic potential.
U2 - 10.1038/s41589-023-01430-2
DO - 10.1038/s41589-023-01430-2
M3 - Journal article
C2 - 37932529
AN - SCOPUS:85175793398
VL - 19
SP - 1551
EP - 1560
JO - Nature Chemical Biology
JF - Nature Chemical Biology
SN - 1552-4450
IS - 12
ER -
ID: 374932139